Clinical Trial

Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy

Study acronym: iTEST R33
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the effectiveness of a psychosocial intervention called iTEST for people with psychotic disorders that targets introspective accuracy, or the ability to accurately gauge ones abilities. iTEST combines daily cognitive training on a mobile device with coaching that addresses recovery goals. In this trial, we will randomize people to one of two interventions conditions, iTEST or a control condition that receives coaching and cognitive training that does not emphasize introspective accuracy. Both interventions will take place over 12 weeks and participants will be asked to complete assessments at baseline, 6 weeks, 12 weeks, and 24 weeks. The primary outcome of the study is community functioning. Participants will be from three metropolitan areas: San Diego, Dallas, or Miami.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-25; most recent amendment 2026-01-22.
Status change: Not Yet Recruiting → Recruiting 2025-09-04
Trial Details
NCT Number NCT07098169
Lead Sponsor University of California, San Diego
Collaborators: National Institute of Mental Health (NIMH), The University of Texas at Dallas, University of Miami
Conditions Schizophrenia Disorders, Schizoaffective Disorder, Psychotic Disorder
Enrollment 201 participants
Start Date 2025-09-01
Primary Completion 2028-02-01 (estimated)
Study Completion 2028-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-23